形态动力学倍性预测模型风险评分与流产及活产结局的关联:一项多中心队列研究
该多中心队列研究纳入英国9家IVF诊所2016-2019年3587例新鲜单胚胎移植,评估PREFER模型的非整倍体风险评分与流产和活产的关系。PREFER低、中、高风险组的流产率分别为12%、14%、22%,PREFER-MK仅与活产相关(低风险组活产率高于高风险组,OR 1.95)。作者认为PREFER对临床因素权重过大,倾向于使用仅含形态动力学指标的模型。
要点
- PREFER模型低、中、高风险组的流产率分别为12%、14%、22%。
- PREFER-MK低风险组活产率显著高于高风险组(OR 1.95,95%CI 1.65-2.25)。
- PREFER-MK高风险与中风险、高风险与低风险相比,流产风险无显著差异。
核心结论
- PREFER模型的风险评分与活产和流产显著相关。
- PREFER模型对临床因素权重过大,无法有效对同一患者的胚胎进行排序,作者认为仅含形态动力学指标的模型更可取。
- PREFER-MK与活产相关,但与流产无关。
研究设计与样本
- 多中心队列研究,纳入英国9家体外受精诊所2016-2019年治疗的患者数据。
- 共纳入3587例新鲜单胚胎移植,排除植入前非整倍体遗传学检测周期。
- PREFER模型基于8147枚活检囊胚标本开发,使用形态动力学和临床生物数据预测倍性状态。
- PREFER-MK为仅使用形态动力学预测因子的第二模型。
- 两个模型均将胚胎分为高风险、中风险和低风险三个非整倍体风险评分类别。
主要发现
- 应用PREFER时,低风险、中风险和高风险类别的流产率分别为12%、14%和22%。
- 被判定为高风险的胚胎其卵子提供者年龄显著高于低风险胚胎,同一年龄患者中风险类别差异很小。
- 使用PREFER-MK时未观察到流产率趋势,但与活产相关:高风险、中风险和低风险组的活产率分别为38%、49%和50%。
- 调整逻辑回归分析显示,PREFER-MK高风险与中风险胚胎相比(OR 0.87,95%CI 0.63-1.63)及高风险与低风险胚胎相比(OR 1.07,95%CI 0.79-1.46),与流产均无显著关联。
- PREFER-MK低风险胚胎较高风险胚胎活产可能性显著更高(OR 1.95,95%CI 1.65-2.25)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether the aneuploidy risk score from a morphokinetic ploidy prediction model, Predicting Euploidy for Embryos in Reproductive Medicine (PREFER), is associated with miscarriage and live birth outcomes. DESIGN: Multicentre cohort study. SETTING: Nine in vitro fertilization clinics in the United Kingdom. PATIENTS: Data were obtained from the treatment of patients from 2016-2019. A total of 3587 fresh single embryo transfers were included; preimplantation genetic testing for aneuploidy) cycles were excluded. INTERVENTION: PREFER is a model developed using 8,147 biopsied blastocyst specimens to predict ploidy status using morphokinetic and clinical biodata. A second model using only morphokinetic (MK) predictors was developed, P PREFER-MK. The models will categorize embryos into the following three risk score categories for aneuploidy: "high risk," "medium risk," and "low risk." MAIN OUTCOME MEASURES: The primary outcomes are miscarriage and live birth. Secondary outcomes include biochemical clinical pregnancy per single embryo transfer. RESULTS: When applying PREFER, the miscarriage rates were 12%, 14%, and 22% in the "low risk," "moderate risk," and "high risk" categories, respectively. Those embryos deemed "high risk" had a significantly higher egg provider age compared with "low risk," and there was little variation in risk categories in patients of the same age. The trend in miscarriage rate was not seen when using PREFER-MK; however, there was an association with live birth, increasing from 38%-49% and 50% in the "high risk," "moderate risk," and "low risk" groups, respectively. An adjusted logistic regression analysis demonstrated that PREFER-MK was not associated with miscarriage when comparing "high risk" to "moderate risk" embryos (odds ratio [OR], 0.87; 95% confidence interval [CI], 0.63-1.63) or "high risk" to "low risk" embryos (OR, 1.07; 95% CI, 0.79-1.46). An embryo deemed "low risk" by PREFER-MK was significantly more likely to result in a live birth than those embryos graded "high risk" (OR, 1.95; 95% CI, 1.65-2.25). CONCLUSION: The PREFER model's risk scores were significantly associated with live births and miscarriages. Importantly, this study also found that this model applied too much weight to clinical factors, such that it could no longer rank a patient's embryos effectively. Therefore, a model including only MKs would be preferred; this was similarly associated with live birth but not miscarriage.
引用
- Bamford T, Smith R, Easter C, et al. Association between a morphokinetic ploidy prediction model risk score and miscarriage and live birth: a multicentre cohort study. Fertil Steril. 2023. PMID: 37307891. doi:10.1016/j.fertnstert.2023.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。